139 related articles for article (PubMed ID: 3530620)
1. [Therapeutic action of a new xanthine derivative in respiratory pathology].
Cesco G; Biondi T; Mazzini R
Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
[No Abstract] [Full Text] [Related]
2. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
[No Abstract] [Full Text] [Related]
3. [Clinico-functional study of the activity of a new xanthine derivative: bamifylline].
Finiguerra M; Morandini GC
Clin Ter; 1986 Jul; 118(2):125-35. PubMed ID: 3527540
[No Abstract] [Full Text] [Related]
4. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
[No Abstract] [Full Text] [Related]
5. Clinical efficacy trial: theophylline vs (dl) 3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione.
Grassi C; Casali L; Rampulla C; Rossi A
Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):518-22. PubMed ID: 7014478
[TBL] [Abstract][Full Text] [Related]
6. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effectiveness of bamifylline in elderly patients with COPD].
Cogo R; Monzani GP; Fusillo M; Vota M
Minerva Med; 1991 Mar; 82(3):115-8. PubMed ID: 2006029
[TBL] [Abstract][Full Text] [Related]
8. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
Lal S; Bhalla KK; Davey AJ
Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
[No Abstract] [Full Text] [Related]
9. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
Eichhorn J; Perré R
Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
[No Abstract] [Full Text] [Related]
10. Theophylline: taking it to a new level.
Messerschmidt K
S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
[No Abstract] [Full Text] [Related]
11. [Bronchodilators: theophylline derivatives].
Neijens HJ
Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
[No Abstract] [Full Text] [Related]
12. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
[No Abstract] [Full Text] [Related]
13. [Theophylline--once or twice daily?].
Schoch C; Menz G; Virchow C
Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
[No Abstract] [Full Text] [Related]
14. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
15. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
Macha HN; Aurich R
Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of reproterol in patients with obstructive pathology of the airways].
Puzio E; Montanero F; Mosca L; Caserta L; Russo V
Clin Ter; 1985 Jan; 112(2):141-4. PubMed ID: 3893858
[No Abstract] [Full Text] [Related]
17. [Why is Etaphylline not better in chronic aspecific respiratory disease?].
Zuidema J; Merkus FW
Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1527-8. PubMed ID: 492369
[No Abstract] [Full Text] [Related]
18. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
[No Abstract] [Full Text] [Related]
19. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
20. Inhibition of methacholine-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
Klaustermeyer WB; Kuhn GJ; Santiago SM; Wehiky I; Hunt EJ
Ann Allergy; 1981 Apr; 46(4):189-92. PubMed ID: 7011112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
